321 related articles for article (PubMed ID: 20001879)
1. New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
Kollef MH
Crit Care Resusc; 2009 Dec; 11(4):282-6. PubMed ID: 20001879
[TBL] [Abstract][Full Text] [Related]
2. New antibiotics for healthcare-associated pneumonia.
Neuner EA; Ritchie DJ; Micek ST
Semin Respir Crit Care Med; 2009 Feb; 30(1):92-101. PubMed ID: 19199191
[TBL] [Abstract][Full Text] [Related]
3. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Loffler CA; Macdougall C
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
[TBL] [Abstract][Full Text] [Related]
4. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
Guskey MT; Tsuji BT
Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
[TBL] [Abstract][Full Text] [Related]
5. New treatments for methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Corey GR
Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
[TBL] [Abstract][Full Text] [Related]
6. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
Eliopoulos GM
J Infect; 2009 Sep; 59 Suppl 1():S17-24. PubMed ID: 19766885
[TBL] [Abstract][Full Text] [Related]
7. New antibiotics in the management of acute bacterial skin and skin structure infections.
Gleghorn K; Grimshaw E; Kelly EK
Skin Therapy Lett; 2015; 20(5):7-9. PubMed ID: 26382907
[TBL] [Abstract][Full Text] [Related]
8. MRSA new treatments on the horizon: current status.
Wilcox MH
Injury; 2011 Dec; 42 Suppl 5():S42-4. PubMed ID: 22196910
[TBL] [Abstract][Full Text] [Related]
9. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Micek ST
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs on methicillin-resistant Staphylococcus aureus.
Liapikou A; Torres A
Expert Opin Emerg Drugs; 2013 Sep; 18(3):291-305. PubMed ID: 23848400
[TBL] [Abstract][Full Text] [Related]
11. Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin.
Steele JM; Seabury RW; Hale CM; Mogle BT
J Clin Pharm Ther; 2018 Feb; 43(1):101-103. PubMed ID: 28628223
[TBL] [Abstract][Full Text] [Related]
12.
Gaikwad V; Gohel T; Panickar S; Chincholkar V; Mangalkar S
Indian J Pathol Microbiol; 2016; 59(4):496-498. PubMed ID: 27721280
[TBL] [Abstract][Full Text] [Related]
13. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Schmidt-Ioanas M; de Roux A; Lode H
Curr Opin Crit Care; 2005 Oct; 11(5):481-6. PubMed ID: 16175036
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial agents in treatment of MRSA infections.
Johnson MD; Decker CF
Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282
[No Abstract] [Full Text] [Related]
15. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Rodvold KA
Clin Infect Dis; 2015 Sep; 61 Suppl 2():S35-7. PubMed ID: 26316556
[No Abstract] [Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.
Rodvold KA; McConeghy KW
Clin Infect Dis; 2014 Jan; 58 Suppl 1():S20-7. PubMed ID: 24343828
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptides--important treatment option for methicillin-resistant Staphylococcus aureus.
Arora S; Arora U
Indian J Med Microbiol; 2011; 29(3):313-4. PubMed ID: 21860119
[No Abstract] [Full Text] [Related]
19. In vitro activity of dalbavancin against staphylococci isolated in Istanbul, Turkey.
Aktas G; Derbentli S
Chemotherapy; 2010; 56(6):444-7. PubMed ID: 21088395
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
Welte T; Pletz MW
Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
